Article
A new design for in-vivo-tissue engineering of musculoskeletal tissue using the inferior epigastric artery central anastomosable vessel of a 3-dimensional construct
Search Medline for
Authors
Published: | September 27, 2011 |
---|
Outline
Text
Introduction: The creation of musculoskeletal tissue represents an alternative for the replacement of tissue after severe damage. However, most of the approaches of creating musculoskeletal tissue have their limitations in the size as the maximally obtainable dimensions of bioartificial tissue are limited due to lack of supporting vessels within the 3-dimensional-construct. The seeded myoblasts require high amounts of perfusion, oxygen and nutrients to survive. To achieve this, we developed a transplantable 3-dimensional-scaffold which features a macroscopic core vessel.
Materials and methods: In animal studies on Wistar rats the inferior epigastric artery was found to be suitable for implantation of an in-vivo bioreactor chamber. After dissecting the epigastric artery with leaving the small branches open the customized chamber was implanted hosting the inferior epigastric artery as central core vessel. Fibrin glue was administered as matrix surrounding the artery in the bioreactor. Luciferase-transfected myoblasts were implemented and followed up by bioluminescence for a period of 7 days.
Results: The implantation of the in-vivo-bioreactor with the epigastric artery as core vessel was done routinely without any side effects or wound problems during the experimental period. The follow-up of the implanted myoblasts by bioluminescence showed a higher cell survival in areas of the open branches of the inferior epigastric artery.
Conclusions: Again, it was shown that the cell survival in-vivo is highly depending on the blood supply. The inferior epigastric artery is easily accessible and therefore usable as a core vessel for in-vivo tissue-engineering in the rat model offering a wide range of further experimental approaches.